全球消化健康補充劑市場規模、佔有率、趨勢和成長分析報告（2026-2034）

預計消化健康補充劑市場將從 2025 年的 218.6 億美元成長到 2034 年的 517.9 億美元，2026 年至 2034 年的複合年成長率為 10.06%。

消化健康補充品市場正經歷顯著成長，這主要得益於消費者尋求改善腸道健康、增強免疫力、提高營養吸收率和促進整體健康的解決方案。含有益生菌、益生元、酵素和膳食纖維的補充劑正被擴大用於解決消化系統疾病、生活方式相關的胃腸道問題以及維持健康的腸道菌叢。日益增強的健康意識、都市化以及機能性食品的流行趨勢正在推動全球需求的成長。

技術創新正在提升產品功效。微膠囊化、菌株特異性益生菌和合合益素配方提高了產品的穩定性、生物利用度和腸道定植率。與基於人工智慧的個人化營養平台相結合，可實現客製化的營養補充劑推薦。永續的原料採購、潔淨標示配方和臨床檢驗增強了消費者信任度，並確保符合監管要求。

預計未來成長將主要受慢性胃腸道疾病盛行率上升、預防醫學普及以及電子商務管道擴張的推動。北美和歐洲憑藉其健康意識強的人口和完善的零售基礎設施佔據主導地位。同時，亞太地區正經歷快速成長，這主要得益於都市區中產階級消費者數量的增加。保健品生產商、生物技術公司和醫療保健平台之間的策略合作正在推動個人化、高效且永續的胃腸道健康解決方案的發展。

目錄

第1章：引言

第2章執行摘要

第3章 市場變數、趨勢與框架

• 市場譜系展望
• 滲透率和成長前景分析
• 價值鏈分析
• 法律規範
  • 標準與合規性
  • 監管影響分析
• 市場動態
  • 市場促進因素
  • 市場限制因素
  • 市場機遇
  • 市場挑戰
• 波特五力分析
• PESTLE分析

第4章：全球消化健康補充品市場：依產品分類

• 市場分析、洞察與預測
• 益生元
• 益生菌
• 酵素
• 富裡酸
• 其他

第5章：全球消化健康補充品市場：以劑型分類

• 市場分析、洞察與預測
• 膠囊
• 藥片
• 粉末
• 液體
• 其他

第6章：全球消化健康補充品市場：依通路分類

• 市場分析、洞察與預測
• OTC
• 處方箋

第7章 全球消化健康補充品市場：按地區分類

• 區域分析
• 北美市場分析、洞察與預測
  • 美國
  • 加拿大
  • 墨西哥
• 歐洲市場分析、洞察與預測
  • 英國
  • 法國
  • 德國
  • 義大利
  • 俄羅斯
  • 其他歐洲國家
• 亞太市場分析、洞察與預測
  • 印度
  • 日本
  • 韓國
  • 澳洲
  • 東南亞
  • 其他亞太國家
• 拉丁美洲市場分析、洞察與預測
  • 巴西
  • 阿根廷
  • 秘魯
  • 智利
  • 其他拉丁美洲國家
• 中東和非洲市場分析、洞察與預測
  • 沙烏地阿拉伯
  • UAE
  • 以色列
  • 南非
  • 其他中東和非洲國家

第8章 競爭情勢

• 最新趨勢
• 公司分類
• 供應鏈和銷售管道合作夥伴（根據現有資訊）
• 市場佔有率和市場定位分析（基於現有資訊）
• 供應商情況（基於現有資訊）
• 策略規劃

第9章：公司簡介

• 主要公司的市佔率分析
• 公司簡介
  • Bayer AG
  • Abbott
  • Glanbia Plc
  • Herbalife Nutrition Ltd
  • Nature'S Bounty
  • Amway Corporation
  • Garden Of Life
  • NU SKIN
  • Lonza Group Ltd
  • NOW Foods

The Digestive Health Supplements Market size is expected to reach USD 51.79 Billion in 2034 from USD 21.86 Billion (2025) growing at a CAGR of 10.06% during 2026-2034.

The digestive health supplements market is experiencing strong growth as consumers seek gut health solutions to improve immunity, nutrient absorption, and overall wellness. Supplements containing probiotics, prebiotics, enzymes, and fiber are increasingly adopted to address digestive disorders, lifestyle-induced gastrointestinal issues, and microbiome health. Rising health awareness, urbanization, and functional food trends are driving global demand.

Technological innovation is advancing product efficacy. Microencapsulation, strain-specific probiotics, and synbiotic formulations improve stability, bioavailability, and gut colonization. Integration with AI-based personalized nutrition platforms enables tailored supplementation recommendations. Sustainable ingredient sourcing, clean-label formulations, and clinical validation are enhancing consumer confidence and regulatory compliance.

Future growth is expected from increasing chronic digestive disorder prevalence, preventive healthcare adoption, and expansion of e-commerce channels. North America and Europe lead due to health-conscious populations and established retail infrastructure, while Asia-Pacific is witnessing rapid growth fueled by rising urban middle-class consumers. Strategic collaborations between supplement manufacturers, biotech innovators, and healthcare platforms are driving personalized, effective, and sustainable digestive health solutions.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Prebiotics
• Probiotics
• Enzymes
• Fulvic Acid
• Others

By Form

• Capsules
• Tablets
• Powders
• Liquids
• Others

By Distribution Channel

• OTC
• Prescribed

COMPANIES PROFILED

• Bayer AG, Abbott, Glanbia plc, Herbalife Nutrition Ltd, Natures Bounty, Amway Corporation, Garden of Life, NU SKIN, Lonza Group Ltd, NOW Foods
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL DIGESTIVE HEALTH SUPPLEMENTS MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Prebiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Probiotics Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Enzymes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Fulvic Acid Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL DIGESTIVE HEALTH SUPPLEMENTS MARKET: BY FORM 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Form
• 5.2. Capsules Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Tablets Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Powders Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.5. Liquids Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.6. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL DIGESTIVE HEALTH SUPPLEMENTS MARKET: BY DISTRIBUTION CHANNEL 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Distribution Channel
• 6.2. OTC Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Prescribed Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL DIGESTIVE HEALTH SUPPLEMENTS MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Form
  • 7.2.3 By Distribution Channel
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Form
  • 7.3.3 By Distribution Channel
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Form
  • 7.4.3 By Distribution Channel
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Form
  • 7.5.3 By Distribution Channel
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Form
  • 7.6.3 By Distribution Channel
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL DIGESTIVE HEALTH SUPPLEMENTS INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bayer AG
  • 9.2.2 Abbott
  • 9.2.3 Glanbia Plc
  • 9.2.4 Herbalife Nutrition Ltd
  • 9.2.5 Nature'S Bounty
  • 9.2.6 Amway Corporation
  • 9.2.7 Garden Of Life
  • 9.2.8 NU SKIN
  • 9.2.9 Lonza Group Ltd
  • 9.2.10 NOW Foods